ANGEL1
protein-codingangel homolog 1
Gene summary
Enables RNA 2',3'-cyclic phosphatase activity; eukaryotic initiation factor 4E binding activity; and protein domain specific binding activity. Involved in nuclear-transcribed mRNA catabolic process, non-stop decay. Located in several cellular components, including cis-Golgi network; endoplasmic reticulum; and perinuclear region of cytoplasm. Is active in mitochondrial outer membrane. [provided by Alliance of Genome Resources, Jun 2026]
- KIAA0759
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~44.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ANGEL1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_015305.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 0 | |||||
| missense | 95 | 3 | 98 | |||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 3 | 3 | ||||
| Total | 0 | 0 | 98 | 3 | 0 | 101 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_056120.2 | 10 | MANE Select | |
| Ensembl | ENSP00000251089.3 | 10 | MANE Select | |
| RefSeq | NP_001357675.1 | 12 | Standard | |
| RefSeq | NP_001357676.1 | 12 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Molecular Function
- eukaryotic initiation factor 4E binding
- protein domain specific binding
Cellular Component
- nucleus
- endoplasmic reticulum
- cis-Golgi network
- cytosol
- perinuclear region of cytoplasm
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000251089
- Coding exons
- 10
- Length
- 39002
- Individuals with no LoFs
- 125358
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 390
- Defined
- 125748
- p
- 0.00155
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.924 | 331 | 382 | 0.867 | 0.0000209 | 4330 |
| Missense (PolyPhen) | 101 | 135.48 | 0.74547 | 1587 | ||
| Synonymous | -0.0196 | 152 | 152 | 1.00 | 0.00000801 | 1366 |
| Loss of Function | 2.61 | 19 | 35.9 | 0.530 | 0.00000212 | 363 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00031 | 0.00031 | rare |
| Latino/Admixed American | 0.0011 | 0.0011 | notable |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0.00065 | 0.00065 | rare |
| European (Non-Finnish) | 0.0015 | 0.0015 | notable |
| South Asian | 0.0053 | 0.0053 | notable |
| Other | 0.00066 | 0.00065 | rare |
dbNSFP Gene Annotations
Source:
Recessive Scores
- pRec
- 0.0875
Intolerance Scores
- LoFtool
- 0.655
- RVIS EVS
- 0.58
- RVIS percentile EVS
- 82.3
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.305
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |